Sfoglia per Autore
Mostrati risultati da 1 a 5 di 5
Is the risk of primary hyperparathyroidismincreased in patients with untreated breast cancer?
2013 V. Belardi, E. Fiore, E. Giustarini, I. Muller, S. Sabatini, V. Rosellini, E. Seregni, R. Agresti, C. Marcocci, P. Vitti, C. Giani
Secondary electrospray ionization-mass spectrometry and a novel statistical bioinformatic approach identifies a cancer-related profile in exhaled breath of breast cancer patients: a pilot study
2015 P. Martinez-Lozano Sinues, E. Landoni, R. Miceli, V.F. Dibari, M. Dugo, R. Agresti, E. Tagliabue, S. Cristoni, R. Orlandi
Evaluation of Local Oncologic Safety in Nipple–Areola Complex-sparing Mastectomy After Primary Chemotherapy : A Propensity Score-matched Study
2017 R. Agresti, M. Sandri, M. Gennaro, G. Bianchi, I. Maugeri, M. Rampa, G. Capri, M.L. Carcangiu, G. Trecate, E. Riggio, L. Lozza, F. de Braud
Correction to: Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients
2018 E. Venturelli, A. Orenti, A.S.C. Fabricio, G. Garrone, R. Agresti, B. Paolini, C. Bonini, M. Gion, F. Berrino, C. Desmedt, D. Coradini, E. Biganzoli
Decoding immune heterogeneity of triple negative breast cancer and its association with systemic inflammation
2019 S. Romero-Cordoba, E. Meneghini, M. Sant, M.V. Iorio, L. Sfondrini, B. Paolini, R. Agresti, E. Tagliabue, F. Bianchi
Mostrati risultati da 1 a 5 di 5
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile